Cerebral vasospasm in subarachnoid haemorrhage

被引:2
|
作者
Stura, G [1 ]
Ferrio, MF [1 ]
Bergui, M [1 ]
机构
[1] Univ Turin, Molinette Hosp, Neuroradiol Unit, Dept Neurosci, I-10126 Turin, Italy
来源
RIVISTA DI NEURORADIOLOGIA | 2002年 / 15卷 / 05期
关键词
vasospasm; cerebral aneurysm; subarachnoid haemorrhage; angioplasty; papaverine;
D O I
10.1177/197140090201500519
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In the second and third weeks after a subarachnoid haemorrhage a series of mechanisms causes a decrease of the diameter of the cerebral vessels. These phenomena are globally included in the term "vasospasm". A certain degree of vasospasm is found in the majority of the patients after a subarachnoid bleeding.. This can be detected by instrumental examinations, in particular trans-cranial doppler and angiography. However, only a minor percentage of these patients will suffer clinical consequences. The vasospasm is currently treated by hypertensive-hypervolemic-haemodilution therapy (the so called "HHH" therapy), or may be treated by selective injection of vasoactive substances (Papaverine, nimodipine) or by mechanical dilatation of the involved vessels with balloons, mainly because of an improved medical management and a better monitoring of critical patients the incidence of clinical vasospasm has decreased in the recent years.
引用
收藏
页码:611 / 614
页数:4
相关论文
共 50 条
  • [31] How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent cerebral infarction in patients with subarachnoid haemorrhage
    Rass, Verena
    Helbok, Raimund
    CURRENT OPINION IN CRITICAL CARE, 2021, 27 (02) : 103 - 114
  • [33] Possible role of tenascin-C in cerebral vasospasm after aneurysmal subarachnoid haemorrhage
    Suzuki, H.
    Kanamaru, K.
    Suzuki, Y.
    Aimi, Y.
    Matsubara, N.
    Araki, T.
    Takayasu, M.
    Takeuchi, T.
    Okada, K.
    Kinoshita, N.
    Imanaka-Yoshida, K.
    Yoshida, T.
    Taki, W.
    CEREBRAL VASOSPASM: NEW STRATEGIES IN RESEARCH AND TREATMENT, 2008, 104 : 179 - +
  • [34] Reversal of Cerebral Vasospasm by the Nitric Oxide Donor SNAP in an Experimental Model of Subarachnoid Haemorrhage
    T. Kırış
    A. Karasu
    C. Yavuz
    T. Erdem
    F. Ünal
    K. Hepgül
    H. Baloğlu
    Acta Neurochirurgica, 1999, 141 : 1323 - 1329
  • [35] Treatment during cerebral vasospasm phase—complication association and outcome in aneurysmal subarachnoid haemorrhage
    Isabel C. Hostettler
    Kornelia Kreiser
    Nicole Lange
    Nina Schwendinger
    Dominik Trost
    Samira Frangoulis
    Theresa Hirle
    Jens Gempt
    Maria Wostrack
    Bernhard Meyer
    Journal of Neurology, 2022, 269 : 5553 - 5560
  • [36] Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm, in patients with a subarachnoid haemorrhage
    Woszczyk, A
    Deinsberger, W
    Böker, DK
    ACTA NEUROCHIRURGICA, 2003, 145 (04) : 257 - 264
  • [37] Endothelin and nitric oxide as cerebrospinal fluid biomarkers for cerebral vasospasm following subarachnoid haemorrhage
    Hegen, Harald
    Deisenhammer, Florian
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2010, 34 (06): : 343 - 347
  • [38] Jugular venous oximetry in a patient with severe cerebral vasospasm after subarachnoid haemorrhage.
    Stordeur, JM
    Bruder, N
    Cantais, E
    Pellissier, D
    Levrier, O
    Gouin, F
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2000, 19 (02): : 111 - 114
  • [39] 867 Transcranial Doppler Ultrasound for the Diagnosis of Cerebral Vasospasm After Aneurysmal Subarachnoid Haemorrhage
    Masala, I
    BRITISH JOURNAL OF SURGERY, 2022, 109 (SUPPL 6)
  • [40] Transcranial Doppler predictive value in patients with cerebral vasospasm after aneurysmal subarachnoid haemorrhage
    Globa, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 45 - 45